The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy
Open accessAbstract
Acute respiratory distress syndrome (ARDS) is caused by infectious insults, such as pneumonia from various pathogens or related to other noninfectious events. Clinical and histopathologic characteristics are similar across severely affected patients, suggesting that a common mode of immune reaction may be involved in the immunopathogenesis of ARDS. There may be etiologic substances that have an affinity for respiratory cells and induce lung cell injury in cases of ARDS. These substances originate not only from pathogens, but also from injured host cells. At the molecular level, these substances have various sizes and biochemical characteristics, classifying them as protein substances and non-protein substances. Immune cells and immune proteins may recognize and act on these substances, including pathogenic proteins and peptides, depending upon the size and biochemical properties of the substances (this theory is known as the protein-homeostasis-system hypothesis). The severity or chronicity of ARDS depends on the amount of etiologic substances with corresponding immune reactions, the duration of the appearance of specific immune cells, or the repertoire of specific immune cells that control the substances. Therefore, treatment with early systemic immune modulators (corticosteroids and/or intravenous immunoglobulin) as soon as possible may reduce aberrant immune responses in the potential stage of ARDS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · cited 2×
“Because both types of immune system cells may communicate with each other in all immunological events, the proteins produced by innate immune system cells may affect the function of adaptive immune system cells, including the expression of costimulatory receptors on adaptive immune cells and the differentiation of T c…”
BackgroundDriving pressure and survival in the acute respiratory distress syndrome.
Amato, M. B. P., Meade, M. O., Slutsky, A. S., Brochard, L., Costa, E. L. V., Schoenfeld, D. A., Stewart, T. E., Briel, M., Talmor, D., Mercat, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1410639 · Cited by 2,801 · cited 1×
“The protective lung ventilation strategies (low tidal volume or limited driving pressure strategy) are currently accepted as major ways to improve the mortality of ARDS, and the main purpose of protective ventilation is to minimize the lung cell injury and avoid the further release of inflammatory mediators from the m…”
Background(2004) · New England Journal of Medicine · doi:10.1056/nejmoa032193 · Cited by 2,565
Wyatt, R. J., & Julian, B. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1206793 · Cited by 1,222
Beutler, B. A. (2009) · Blood · doi:10.1182/blood-2008-07-019307 · Cited by 840
Sagar, S., Liu, P. P., & Cooper, L. T. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60648-x · Cited by 743
Human immunopathogenesis of severe acute respiratory syndrome (SARS)
Cameron, M. J., Bermejo-Martin, J. F., Danesh, A., Muller, M. P., & Kelvin, D. J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.02.014 · Cited by 391
Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS.
Sheu, C.-C., Gong, M. N., Zhai, R., Chen, F., Bajwa, E. K., Clardy, P. F., Gallagher, D. C., Thompson, B. T., & Christiani, D. C. (2010) · Chest · doi:10.1378/chest.09-2933 · Cited by 260
Nakajima, N., Sato, Y., Katano, H., Hasegawa, H., Kumasaka, T., Hata, S., Tanaka, S., Amano, T., Kasai, T., Chong, J.-M., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.125 · Cited by 95 · cited 1×
“However, typical pathologies of advanced ARDS patients and animals show similar findings, including diffuse alveolar damage, hyaline membrane formation along alveolar walls, and extensive immune cell infiltration such as neutrophils and T cells in lung parenchyma and around damaged alveoli [44,45].”
Background
Cited by
Kellner, M., Noonepalle, S., Lu, Q., Srivastava, A., Zemskov, E., & Black, S. M. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-63245-2_8 · Cited by 402
Harrell, C. R., Sadikot, R., Pascual, J., Fellabaum, C., Jankovic, M. G., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V. (2019) · Stem Cells International · doi:10.1155/2019/4236973 · Cited by 193
“An increased concentration of these inflammatory chemokines in inflamed lungs attract interferon gamma- (IFN-γ-) producing neutrophils and CD4+Th1 cells which, in turn, enhance the secretion of inflammatory cytokines and proteolytic enzymes in alveolar macrophages, creating a “positive inflammatory loop” in the injure…”
Background
Metadata
- Authors
- Lee, K.-Y.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-02-11
- Volume
- 18
- Issue
- 2
- Pages
- 388
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2556426925
- Cited by
- 163
- References
- 9
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy. https://app.cochat.ai/papers/10.3390/ijms18020388
- The paper
- Lee, K.-Y. (2017). Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms18020388
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.